Would you offer SBRT to a patient with RCC oligometastasis to the lung on belzutifan?
In that case, what is your dose/fractionation? Additional dose constraints? Would you hold belzutifan during RT?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University Hospital Basel
Answered on
Generally speaking, yes.
I would offer SBRT, however the treatment intention has to be defined first.
Is this a patient with oligometastatic, oligopersistent or oligoprogressive disease? What is the precise goal of SBRT (PFS or symptom control - for instance due to a central location of the metastasi...
Join for free or sign in to see the full answer